The shelf life of Johnson & Johnson's COVID vaccine has been extended from 3 months to 4.5 months by the US Food and Drug Administration.

"Evidence from our Phase 3 ENSEMBLE study demonstrates the efficacy of our single-shot COVID-19 vaccine, including against viral variants that are highly prevalent. Regardless of race and ethnicity, age, geographic location and comorbidities, these results remain consistent," the company said in a statement.
Source-IANS
MEDINDIA














